221
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes

, , , , , , & show all
Pages 31-37 | Received 31 Jul 2017, Accepted 25 Sep 2017, Published online: 12 Oct 2017

References

  • Broderick P, Dobbins SE, Chubb D, et al. Validation of recently proposed colorectal cancer susceptibility gene variants in an analysis of families and patients – a systematic review. Gastroenterology. 2017;152:75–77.
  • Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology. 2014;147:502–526.
  • Newton KF, Mallinson EK, Bowen J, et al. Genotype-phenotype correlation in colorectal polyposis. Clin Genet. 2012;81:521–531.
  • Resta N, Pierannunzio D, Lenato GM, et al. Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study. Dig Liver Dis. 2013;45:606–611.
  • Ponz de Leon M, Di Gregorio C, Giunti L, et al. Duodenal carcinoma in a 37-year-old man with Cowden/Bannayan syndrome. Dig Liver Dis. 2013;45:75–78.
  • Hendriks YM, Wagner A, Morreau H, et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology. 2004;127:17–25.
  • Vasen HF, Ghorbanoghli Z, Bourdeaut F, et al. Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D). J Med Genet. 2014;51:283–293.
  • Ponz de Leon M, Antonioli A, Ascari A, et al. Incidence and familial occurrence of colorectal cancer and polyps in a health-care district of northern Italy. Cancer. 1987;60:2848–2859.
  • Ponz de Leon M, Benatti P, Percesepe A, et al. Epidemiology of cancer of the large bowel–the 12-year experience of a specialized registry in northern Italy. Ital J Gastroenterol Hepatol. 1999;31:10–18.
  • Vasen HF, Watson P, Mecklin JP. et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116:1453–1456.
  • Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789–799.
  • Roncari B, Pedroni M, Maffei S, et al. Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. Clin Genet. 2007;72:230–237.
  • Pastrello C, Pin E, Marroni F, et al. Integrated analysis of unclassified variants in mismatch repair genes. Genet Med. 2011;13:115–124.
  • Thompson BA, Spurdle AB, Plazzer JP, et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet. 2014;46:107–115.
  • Caluseriu O, Di Gregorio C, Lucci-Cordisco E, et al. A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. J Med Genet. 2004;41:e34.
  • Ponz de Leon M, Benatti P, Di Gregorio C, et al. Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer. Scand J Gastroenterol. 2007;42:746–753.
  • Gill P, Wang LM, Bailey A, et al. Reporting trends of right-sided hyperplastic and sessile serrated polyps in a large teaching hospital over a 4-year period (2009–2012). J Clin Pathol. 2013;66:655–658.
  • Shussman N, Wexner SD. Colorectal polyps and polyposis syndromes. Gastroenterol Rep (Oxf). 2014;2:1–15.
  • Chetty R, Hafezi-Bakhtiari S, Serra S, et al. Traditional serrated adenomas (TSAs) admixed with other serrated (so-called precursor) polyps and conventional adenomas: a frequent occurrence. J Clin Pathol. 2014;68:270–273.
  • Committee on Practice Bulletins—Gynecology and the Society of Gynecologic Oncology. Practice Bulletin No. 147: Lynch Syndrome. Obstet Gynecol. 2014;124;1042–1054.
  • Jenkins MA, Dowty JG, Ait Ouakrim D, et al. Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis. J Clin Oncol. 2015;33:326–331.
  • Mecklin JP. Molecular genotype/clinical phenotype relationship in HNPCC (abstract). In: Khan PM, Morh J, editors. Genetics of FAP and HNPCC. Proceedings of the 5th workshop. Budapest (Hungary). 1994. p. 38–39.
  • Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet. 1997;93:84–99.
  • Talseth-Palmer BA, Wijnen JT, Grice DM, et al. Genetic modifiers of cancer risk in Lynch syndrome: a review. Fam Cancer. 2013;12:207–216.
  • Orlando G, Law PJ, Palin K, et al. Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease. Hum Mol Genet. 2016;25:2349–2359.
  • Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–932.
  • Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223–262. quiz 263.
  • Potter JD. Vegetables, fruit, and cancer. Lancet. 2005;366:527–530.
  • Friedenreich C, Norat T, Steindorf K, et al. Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2006;15:2398–2407.
  • Lynch PM, Ayers GD, Hawk E, et al. The safety and efficacy of celecoxib in children with familial adenomatous polyposis. Am J Gastroenterol. 2010;105:1437–1443.
  • Phillips RK, Wallace MH, Lynch PM, et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut. 2002;50:857–860.
  • Watson P, Riley B. The tumor spectrum in the Lynch syndrome. Fam Cancer. 2005;4:245–248.
  • Järvinen HJ, Renkonen-Sinisalo L, Aktán-Collán K, et al. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol. 2009;27:4793–4797.
  • Win AK, Lindor NM, Young JP, et al. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst. 2012;104:1363–1372.
  • Therkildsen C, Ladelund S, Rambech E, et al. Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome. Eur J Neurol. 2015;22:717–724.
  • Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: two genetic diseases? J Clin Oncol. 1997;15:2744–2758.
  • Johannesma PC, van der Klift HM, van Grieken NC, et al. Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations. Clin Genet. 2011;80:243–255.
  • Durno C, Boland CR, Cohen S, et al. Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;152:1605–1614.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.